🇺🇸 FDA
Pipeline program

ONX-0801

CCR3941

Phase 1 small_molecule completed

Quick answer

ONX-0801 for Solid Tumours is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Solid Tumours
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials